Prenuvo's $120 Million Bet on Preventative Health: A New Era of Whole-Body Scanning
February 14, 2025, 3:34 pm
Location: United States, California, Redwood City
Employees: 51-200
Founded date: 2018
Total raised: $190M
Prenuvo is on a mission. With a fresh $120 million in funding, the Redwood City-based company is redefining preventative healthcare. The goal? To empower individuals with knowledge about their health before symptoms arise. This isn’t just a business venture; it’s a revolution in how we perceive and manage our well-being.
Prenuvo specializes in whole-body MRI scans. These scans are not your typical medical procedures. They are proactive, non-invasive, and designed to catch potential health issues early. For $2,500, patients can undergo a full-body scan that checks for a myriad of conditions, including cancer and aneurysms. This service has garnered attention, even from celebrities, and has led to a rapid increase in demand.
The recent funding round was co-led by Forerunner Ventures, Left Lane Capital, and existing investor Felicis. With this capital, Prenuvo plans to expand its operations and enhance its offerings. The company is not just resting on its laurels; it’s pushing the envelope.
Three new health assessments are on the horizon. First, an FDA-cleared AI-powered body composition analysis. This tool provides detailed insights into visceral fat, liver fat, muscle volume, and the health of vital organs. It’s like having a personal trainer and a nutritionist rolled into one, offering actionable data to help patients make informed lifestyle choices.
Next up is a brain health scan. This innovative test will provide critical information about cognitive function and early indicators of neurodegenerative diseases. In a world where mental health is increasingly prioritized, this scan could be a game-changer.
Lastly, Prenuvo is introducing a comprehensive blood biomarker assessment. This custom-built panel will offer insights into metabolic, cardiovascular, hormonal, and immune health. The combination of imaging and blood tests is a powerful duo, creating a holistic view of a patient’s health. It’s not just about seeing what’s wrong; it’s about understanding the entire picture.
The company’s growth trajectory is impressive. Prenuvo has surpassed 110,000 members and generated $100 million in revenue last year. It operates 17 clinics across North America and plans to open 15 more locations, including sites in Europe and Australia. This expansion is not just about numbers; it’s about accessibility. Prenuvo aims to make preventative healthcare available to more people.
Critics have raised eyebrows at Prenuvo’s pricing. The $2,500 full-body scan and the new package, which includes additional tests for $3,999, may seem steep. However, the company argues that the cost of early detection far outweighs the potential expenses of treating advanced diseases. In a sense, it’s an investment in one’s future health.
The healthcare landscape is changing. Traditional models often focus on treatment rather than prevention. Prenuvo is flipping this script. Patients are increasingly seeking alternatives to the conventional healthcare system. They want proactive solutions, not reactive ones. Prenuvo is answering that call.
The company’s approach is rooted in technology. With the largest repository of whole-body MRI imaging in the world, Prenuvo is well-positioned to leverage artificial intelligence. This technology can enhance the accuracy of scans and improve the efficiency of radiologists. It’s a blend of cutting-edge science and compassionate care.
Prenuvo’s CEO, Andrew Lacy, emphasizes the importance of patient empowerment. When individuals understand their health, they can take control. Early diagnosis leads to early intervention, which can be life-saving. This philosophy is at the heart of Prenuvo’s mission.
The new assessments will initially be available in select locations, including Silicon Valley, Los Angeles, and New York. As demand grows, Prenuvo plans to roll out these services more broadly. The company is committed to providing a premium experience, even sending trained phlebotomists to patients’ homes for blood draws.
This level of service is designed to make patients feel comfortable and cared for. Prenuvo understands that healthcare can be intimidating. By creating a calming environment, they aim to alleviate some of that anxiety.
As Prenuvo continues to innovate, it faces competition. Other startups, like Ezra, are also entering the full-body MRI space. However, Prenuvo’s comprehensive approach sets it apart. By combining imaging with blood tests and AI, the company is creating a unique offering that could redefine preventative healthcare.
In conclusion, Prenuvo is not just another health tech startup. It’s a pioneer in a new era of healthcare. With its recent funding and innovative services, the company is poised to make a significant impact. As it expands its reach and enhances its offerings, Prenuvo is leading the charge toward a future where individuals take charge of their health. This is more than just a trend; it’s a movement. The landscape of healthcare is shifting, and Prenuvo is at the forefront, ready to guide patients on their journey to better health.
Prenuvo specializes in whole-body MRI scans. These scans are not your typical medical procedures. They are proactive, non-invasive, and designed to catch potential health issues early. For $2,500, patients can undergo a full-body scan that checks for a myriad of conditions, including cancer and aneurysms. This service has garnered attention, even from celebrities, and has led to a rapid increase in demand.
The recent funding round was co-led by Forerunner Ventures, Left Lane Capital, and existing investor Felicis. With this capital, Prenuvo plans to expand its operations and enhance its offerings. The company is not just resting on its laurels; it’s pushing the envelope.
Three new health assessments are on the horizon. First, an FDA-cleared AI-powered body composition analysis. This tool provides detailed insights into visceral fat, liver fat, muscle volume, and the health of vital organs. It’s like having a personal trainer and a nutritionist rolled into one, offering actionable data to help patients make informed lifestyle choices.
Next up is a brain health scan. This innovative test will provide critical information about cognitive function and early indicators of neurodegenerative diseases. In a world where mental health is increasingly prioritized, this scan could be a game-changer.
Lastly, Prenuvo is introducing a comprehensive blood biomarker assessment. This custom-built panel will offer insights into metabolic, cardiovascular, hormonal, and immune health. The combination of imaging and blood tests is a powerful duo, creating a holistic view of a patient’s health. It’s not just about seeing what’s wrong; it’s about understanding the entire picture.
The company’s growth trajectory is impressive. Prenuvo has surpassed 110,000 members and generated $100 million in revenue last year. It operates 17 clinics across North America and plans to open 15 more locations, including sites in Europe and Australia. This expansion is not just about numbers; it’s about accessibility. Prenuvo aims to make preventative healthcare available to more people.
Critics have raised eyebrows at Prenuvo’s pricing. The $2,500 full-body scan and the new package, which includes additional tests for $3,999, may seem steep. However, the company argues that the cost of early detection far outweighs the potential expenses of treating advanced diseases. In a sense, it’s an investment in one’s future health.
The healthcare landscape is changing. Traditional models often focus on treatment rather than prevention. Prenuvo is flipping this script. Patients are increasingly seeking alternatives to the conventional healthcare system. They want proactive solutions, not reactive ones. Prenuvo is answering that call.
The company’s approach is rooted in technology. With the largest repository of whole-body MRI imaging in the world, Prenuvo is well-positioned to leverage artificial intelligence. This technology can enhance the accuracy of scans and improve the efficiency of radiologists. It’s a blend of cutting-edge science and compassionate care.
Prenuvo’s CEO, Andrew Lacy, emphasizes the importance of patient empowerment. When individuals understand their health, they can take control. Early diagnosis leads to early intervention, which can be life-saving. This philosophy is at the heart of Prenuvo’s mission.
The new assessments will initially be available in select locations, including Silicon Valley, Los Angeles, and New York. As demand grows, Prenuvo plans to roll out these services more broadly. The company is committed to providing a premium experience, even sending trained phlebotomists to patients’ homes for blood draws.
This level of service is designed to make patients feel comfortable and cared for. Prenuvo understands that healthcare can be intimidating. By creating a calming environment, they aim to alleviate some of that anxiety.
As Prenuvo continues to innovate, it faces competition. Other startups, like Ezra, are also entering the full-body MRI space. However, Prenuvo’s comprehensive approach sets it apart. By combining imaging with blood tests and AI, the company is creating a unique offering that could redefine preventative healthcare.
In conclusion, Prenuvo is not just another health tech startup. It’s a pioneer in a new era of healthcare. With its recent funding and innovative services, the company is poised to make a significant impact. As it expands its reach and enhances its offerings, Prenuvo is leading the charge toward a future where individuals take charge of their health. This is more than just a trend; it’s a movement. The landscape of healthcare is shifting, and Prenuvo is at the forefront, ready to guide patients on their journey to better health.